Based on 8 analysts giving stock ratings to Connect Biopharma Holdings Ltd in the past month.
In the current month, CNTB has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CNTB average Analyst price target in the last month is 6.000.
Based on analysts' estimates, CNTB EPS is projected to reach -0.040 in FY2026Q3, following reported EPS of -0.275 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.27, while Connect Biopharma Holdings LtdCNTB's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.04.